Results 21 to 30 of about 3,383,893 (307)

Factors affecting the changes in antihypertensive medications in patients with hypertension

open access: yesFrontiers in Cardiovascular Medicine, 2022
As frequent changes in anti-hypertensive (HTN) medications may reduce adherence to the treatments, identifying modifiable factors leading to changes in anti-HTN medications can help clinicians optimize treatment strategies for individual patients.
Tae Kyu Chung   +14 more
doaj   +1 more source

Failure of diltiazem to prevent 1:1 conduction of atrial flutter: a case report

open access: yesJournal of Medical Case Reports, 2023
Background Atrial flutter with 1:1 conduction to the ventricles is a dangerous cardiac arrhythmia. Contemporary guidelines recommend atrioventricular nodal blocking agents should be co-administered with class 1C anti-arrhythmics, as prophylaxis against 1:
K. D. Tiver   +4 more
doaj   +1 more source

Intravenous Amiodarone versus Digoxin in Atrial Fibrillation Rate Control; a Clinical Trial

open access: yesEmergency, 2016
Introduction: Treatment of rapid ventricular response arterial fibrillation (rapid AF) varies depending on the decision of the in-charge physician, condition of the patient, availability of the drug, and the treatment protocol of the hospital.
Majid Shojaee   +4 more
doaj   +1 more source

Intravenous Amiodarone versus Digoxin in Atrial Fibrillation Rate Control; a Clinical Trial

open access: yesArchives of Academic Emergency Medicine, 2017
Introduction: Treatment of rapid ventricular response arterial fibrillation (rapid AF) varies depending on the decision of the in-charge physician, condition of the patient, availability of the drug, and the treatment protocol of the hospital.
Majid Shojaee   +4 more
doaj   +1 more source

Ventricular Arrhythmias in First Acute Myocardial Infarction: Epidemiology, Mechanisms, and Interventions in Large Animal Models

open access: yesFrontiers in Cardiovascular Medicine, 2019
Ventricular arrhythmia and subsequent sudden cardiac death (SCD) due to acute myocardial infarction (AMI) is one of the most frequent causes of death in humans.
Stefan Michael Sattler   +8 more
doaj   +1 more source

A preliminary assessment of the effects of ATI-2042 in subjects with paroxysmal atrial fibrillation using implanted pacemaker methodology [PDF]

open access: yes, 2009
Aims ATI-2042 (budiodarone) is a chemical analogue of amiodarone with a half life of 7 h. It is electrophysiologically similar to amiodarone, but may not have metabolic and interaction side effects.
Camm, AJ   +5 more
core   +1 more source

Diclofenac Prolongs Repolarization in Ventricular Muscle with Impaired Repolarization Reserve [PDF]

open access: yes, 2012
Background: The aim of the present work was to characterize the electrophysiological effects of the non-steroidal anti- inflammatory drug diclofenac and to study the possible proarrhythmic potency of the drug in ventricular muscle.
Juhász Viktor   +36 more
core   +2 more sources

Design, Synthesis and Biological Evaluation of a Novel Series of Thiadiazole-Based Anticancer Agents as Potent Angiogenesis Inhibitors

open access: yes, 2021
Background: Thiadiazole has attracted a great deal of interest as a versatile heterocycle for the discovery and development of potent anticancer agents. Thiadiazole derivatives exert potent antitumor activity against a variety of human cancer cell lines ...
Turan, Gulhan   +10 more
core   +1 more source

A multicenter retrospective cohort study on predicting the risk for amiodarone pulmonary toxicity

open access: yesBMC Pulmonary Medicine, 2022
Background Amiodarone is one of the most commonly used anti-arrhythmic agents. Amiodarone pulmonary toxicity is a potentially fatal adverse effect associated with amiodarone use.
Wang Chun Kwok   +4 more
doaj   +1 more source

Cardiac TdP risk stratification modelling of anti-infective compounds including chloroquine and hydroxychloroquine

open access: yesRoyal Society Open Science, 2021
Hydroxychloroquine (HCQ), the hydroxyl derivative of chloroquine (CQ), is widely used in the treatment of rheumatological conditions (systemic lupus erythematosus, rheumatoid arthritis) and is being studied for the treatment and prevention of COVID-19 ...
Dominic G. Whittaker   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy